✦ LIBER ✦

Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma

✍ Scribed by Seok Jin Kim; Sung Yong Oh; Jin Seok Kim; Hawk Kim; Gyeong-Won Lee; Jong Ho Won; Ho Jin Shin; Deok Hwan Yang; Chul Won Choi; Jinny Park; Won Seog Kim; Cheolwon Suh

Publisher: Springer
Year: 2010
Tongue: English
Weight: 233 KB
Volume: 90
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-010-1104-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Central nervous system (CNS) relapse in

Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab

✍ W. M. Tai; J. Chung; P. L. Tang; Y. X. Koo; X. Hou; K. W. Tay; R. Quek; M. Tao; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 258 KB

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Kacey O'Rourke; Kirk Morris; Glen A. Kennedy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Matthew Hellmann; Jeffrey A. Barnes; Peter Hammerman; Christ 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

Reply to intravenous methotrexate as cen

Reply to intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Ephraim P. Hochberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

I read with great interest the article by Cooperberg and coworkers 1 studying survival rates in differently treated men with early prostate cancer. In this study, patients who underwent radical prostatectomy had a substantially decreased disease-specific mortality, particularly in the higher-risk gr

Risk factors for poor treatment outcome

Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement

✍ Keun-Wook Lee; Jongyoun Yi; In Sil Choi; Jee Hyun Kim; Soo-Mee Bang; Dong-Wan Ki 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 443 KB

β2-microglobulin aberrations in diffuse

β2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system

✍ Ekaterina S. Jordanova; Sietske A. Riemersma; Katja Philippo; Ed Schuuring; Phil 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 233 KB

## Abstract Human leukocyte antigen (HLA) class I molecules are expressed on the surface of all nucleated cells and present antigenic peptides to cytotoxic T cells, thereby playing an important role in initiating the cellular anti‐tumor immune response. We previously reported that loss of HLA class